|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-4-7
|
|
pubmed:abstractText |
This analysis was performed to assess whether beta-adrenergic blocking agent use is associated with reduced mortality in the Studies of Left Ventricular Dysfunction (SOLVD) and to determine if this relationship is altered by angiotensin-converting enzyme (ACE) inhibitor use.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
916-23
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10091816-Adrenergic beta-Antagonists,
pubmed-meshheading:10091816-Adult,
pubmed-meshheading:10091816-Aged,
pubmed-meshheading:10091816-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:10091816-Cause of Death,
pubmed-meshheading:10091816-Drug Therapy, Combination,
pubmed-meshheading:10091816-Enalapril,
pubmed-meshheading:10091816-Female,
pubmed-meshheading:10091816-Hemodynamics,
pubmed-meshheading:10091816-Humans,
pubmed-meshheading:10091816-Male,
pubmed-meshheading:10091816-Middle Aged,
pubmed-meshheading:10091816-Retrospective Studies,
pubmed-meshheading:10091816-Survival Rate,
pubmed-meshheading:10091816-Systole,
pubmed-meshheading:10091816-Ventricular Dysfunction, Left,
pubmed-meshheading:10091816-Ventricular Function, Left
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction.
|
|
pubmed:affiliation |
Clinical Trials Scientific Research Group, National Heart, Lung and Blood Institute, Bethesda, Maryland 20892, USA. ExnerD@gwgate.nhlbi.nih.gov
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
